At least two airlines are testing CommonPass, a new technology designed to let passengers prove they’ve tested negative for COVID-19 before they fly.

Proponents tout the CommonPass technology as a panacea for global travel in a pandemic world. They hope that a public weary of COVID-19 lockdowns and restrictions — but still fearful of the virus — will embrace it.

But civil rights and privacy groups warn against any technology that monitors individuals’ movements and activities. That includes any digital health pass, like CommonPass, that can be adapted to provide proof of vaccination.

Here’s how CommonPass works. An individual takes a COVID-19 test at an approved lab, then uploads the results to a smartphone. At the airport, airline staff and border officials scan a QR code from the phone, which certifies that the passenger is COVID-19 free.

The groups behind CommonPass — The Commons Project and the World Economic Forum — say the technology has the potential to create a universal digital platform for COVID-19 testing that, if adopted across all governments, could hasten the reopening of international borders.

As it stands now, each government determines its own rules and procedures for quarantines and border entry. That’s unacceptable, according to the World Economic Forum’s head of mobility, Christoph Wolff. In a statement, Wolff said: “Individual national responses will not be sufficient to address this global crisis.”

The Electronic Frontier Foundation, a nonprofit that advocates for civil liberties in a digital world, takes a different view. In May, the group stated its opposition to any type of “immunity passport” that would require “people to present supposed proof of immunity to COVID-19 in order to access public spaces, work sites, airports, school or other venues.”

Electronic Frontier Foundation argues that such technology threatens privacy and “would be a significant step toward a system of national digital identification that can be used to collect and store our personal information and track our location.”

The American Civil Liberties Union similarly warned against “immunity surveillance infrastructure” and “conditioning travel on COVID-19 immunity.”

Still, proponents like Dr. Bradley Perkins, former chief strategy and innovation officer at the U.S. Centers for Disease Control and Prevention — and now chief medical officer for The Commons Project — argue that proof-of-immunity technology is the solution to opening up borders. Perkins told the travel magazine, Afar:

“Without the ability to trust COVID-19 tests — and eventually vaccine records — across international borders, many countries will feel compelled to retain full travel bans and mandatory quarantines for as long as the pandemic persists.”

With suicides, clinical depression, domestic violence and small business closures on the rise during COVID-19 lockdowns and travel restrictions, will a public hungry for a “return to normal” side with civil liberties groups? Or will they see CommonPass as a reasonable trade-off for increased mobility and perceived safety?

We’ll soon find out. On Oct. 8, two airlines launched trial runs. United Airlines tested CommonPass with volunteers flying between New York and London. Cathay Pacific did the same for passengers flying between Hong Kong and Singapore. The U.S. Customs and Border Patrol and the U.S. Centers for Disease Control and Prevention observed the process.

CommonPass said in a press release that after the trials it plans to expand to more airlines and routes across the globe. Right now it’s limited to certifying negative COVID-19 tests. But in the future, CommonPass will be able to certify proof of vaccination, the company said. This means that even if a future COVID-19 vaccine is not mandated globally, airlines could require CommonPass for anyone wishing to travel, domestically or internationally.

“The hope is that the CommonPass will ultimately help reduce or eliminate […] quarantine requirements,” according to the article in Afar.

The idea of deploying digital health technology on a global scale isn’t new. As far back as 2010, The Rockefeller Foundation — whose president, Rajiv Shah, once ran the vaccine financing operation for the Gates Foundation — simulated a series of plausible “scenario narratives” that might unfold in response to a pandemic.

The foundation described one of these scenarios as a “world of tighter top-down government control and more authoritarian leadership.” The foundation lists biometric IDs as one element of this “more controlled world” where “citizens willingly gave up some of their sovereignty — and their privacy.”

The Rockefeller Foundation, which has ties to Big Pharma, has provided funding for The Commons Project, including through a $300,000 grant in 2019 and a $500,000 grant in 2020.

The Commons Project markets itself as “beholden to no one government.” Yet the project has deep ties to COVID-19 vaccine manufacturers, who will inevitably benefit if their products are mandated in order for people to travel across borders. The foundation partners directly with the Pfizer Foundation and Novartis Foundation, both founded by pharmaceutical manufacturers that have COVID-19 vaccines in development.

The Commons Project Foundation also works in partnership with the CARIN Alliance, a digital healthcare group affiliated with Pfizer.

Pfizer CEO Henry McKinell once hailed Klaus Schwab, founder and chairman of the World Economic Forum, as “a person dedicated to a truly noble cause.”

In his book, “COVID-19: The Great Reset,” Schwab echoes Bill Gates’ sentiment that “a full return to ‘normal’ cannot be envisaged before a vaccine is available.” Schwab also writes, “The next hurdle is the political challenge of vaccinating enough people worldwide with a high enough compliance rate despite the rise of anti-vaxxers.”

Jeremy Loffredo is a reporter for Children’s Health Defense.